A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
- 8 October 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 323 (1) , 242-248
- https://doi.org/10.1016/j.bbrc.2004.08.083
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injuryCardiovascular Research, 2004
- Adiponectin and Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Globular Adiponectin Protected ob/ob Mice from Diabetes and ApoE-deficient Mice from AtherosclerosisJournal of Biological Chemistry, 2003
- Disruption of Adiponectin Causes Insulin Resistance and Neointimal FormationJournal of Biological Chemistry, 2002
- Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of IkkβScience, 2001
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001
- The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB ActivationPublished by Elsevier ,1997
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995